“Lecture sessions on manufacturing and real-world examples were especially valuable. The concrete case studies helped translate complex regulatory guidance into practical recommendations that I can apply in my work. I also appreciated the discussions around safety testing, risk assessment, and validation, which provided a clearer understanding of how products move from development to clinical use.”

“The course provided strong insights into regulatory considerations and GMP requirements for cell and gene therapy manufacturing. I particularly valued the sessions on facility setup, quality control, and compliance differences between product classifications. The program highlighted both the scientific and operational challenges involved in bringing advanced therapies to patients.”

“I found the workshop highly informative, especially the discussions on manufacturing workflows, scale-up considerations, and real-world implementation challenges. The interactive case studies and concrete examples helped illustrate how theoretical concepts apply to industry practice. Overall, the training offered meaningful insights into the complexities of translating cell therapy products into clinical settings.”